BIOMAT Database Logo BIOMAT Database Logo

How should chronic hepatitis B virus infection be managed in HIV-hepatitis B virus-coinfected patients not eligible for concomitant antiretroviral therapy? 2008

Hélène Castel, and Laurence Bocket, and Catherine Tamalet, and Marc Bourlière, and Yazdan Yazdanpanah

UI MeSH Term Description Entries
D008297 Male Males
D005260 Female Females
D006147 Guanine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D017088 AIDS-Related Opportunistic Infections Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus. HIV-Related Opportunistic Infections,Opportunistic Infections, AIDS-Related,Opportunistic Infections, HIV-Related,AIDS Related Opportunistic Infections,AIDS-Related Opportunistic Infection,HIV Related Opportunistic Infections,HIV-Related Opportunistic Infection,Infection, HIV-Related Opportunistic,Infections, HIV-Related Opportunistic,Opportunistic Infection, AIDS-Related,Opportunistic Infection, HIV-Related,Opportunistic Infections, AIDS Related,Opportunistic Infections, HIV Related
D017410 Practice Guidelines as Topic Works about directions or principles presenting current or future rules of policy for assisting health care practitioners in patient care decisions regarding diagnosis, therapy, or related clinical circumstances. The guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by the convening of expert panels. The guidelines form a basis for the evaluation of all aspects of health care and delivery. Clinical Guidelines as Topic,Best Practices,Best Practice
D019694 Hepatitis B, Chronic INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Chronic Hepatitis B,Chronic Hepatitis B Virus Infection,Hepatitis B Virus Infection, Chronic

Related Publications

Hélène Castel, and Laurence Bocket, and Catherine Tamalet, and Marc Bourlière, and Yazdan Yazdanpanah
Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls.
October 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Hélène Castel, and Laurence Bocket, and Catherine Tamalet, and Marc Bourlière, and Yazdan Yazdanpanah
Tenofovir for chronic hepatitis B virus infection in HIV-coinfected patients.
April 2006, The AIDS reader,
Hélène Castel, and Laurence Bocket, and Catherine Tamalet, and Marc Bourlière, and Yazdan Yazdanpanah
Virological outcome of chronic hepatitis B virus infection in HIV-coinfected patients receiving anti-HBV active antiretroviral therapy.
September 2006, AIDS research and human retroviruses,
Hélène Castel, and Laurence Bocket, and Catherine Tamalet, and Marc Bourlière, and Yazdan Yazdanpanah
Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption.
March 2010, AIDS (London, England),
Hélène Castel, and Laurence Bocket, and Catherine Tamalet, and Marc Bourlière, and Yazdan Yazdanpanah
[How long should patients with chronic hepatitis B virus infection be treated].
November 2006, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
Hélène Castel, and Laurence Bocket, and Catherine Tamalet, and Marc Bourlière, and Yazdan Yazdanpanah
Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviral therapy.
July 2001, Journal of acquired immune deficiency syndromes (1999),
Hélène Castel, and Laurence Bocket, and Catherine Tamalet, and Marc Bourlière, and Yazdan Yazdanpanah
Antiretroviral therapy does not affect response to chronic hepatitis C therapy in HIV-coinfected patients.
August 2016, Journal of infection in developing countries,
Hélène Castel, and Laurence Bocket, and Catherine Tamalet, and Marc Bourlière, and Yazdan Yazdanpanah
Hepatitis B virus seroconversion in HIV-HBV coinfected patients treated with highly active antiretroviral therapy.
April 2000, Journal of acquired immune deficiency syndromes (1999),
Hélène Castel, and Laurence Bocket, and Catherine Tamalet, and Marc Bourlière, and Yazdan Yazdanpanah
Risk factors for acute liver enzyme abnormalities in HIV-hepatitis B virus-coinfected patients on antiretroviral therapy.
January 2007, Antiviral therapy,
Hélène Castel, and Laurence Bocket, and Catherine Tamalet, and Marc Bourlière, and Yazdan Yazdanpanah
Evolution of hepatitis C virus in HIV coinfected patients under antiretroviral therapy.
September 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases,
Copied contents to your clipboard!